Journal of Nuclear Medicine: 47 (6)

About the Cover

June 2006; Volume 47,Issue 6

This Month in JNM

You have access
This Month in JNM
Journal of Nuclear Medicine June 1, 2006, 47 (6) 11a-12a;

SNM Newsline

You have access
SNM Annual Meeting Focuses on Molecular Imaging/Nuclear Medicine Research
Journal of Nuclear Medicine June 1, 2006, 47 (6) 13N;
You have access
A Memoir of Pediatric Nuclear Medicine: Part III: Finding a Place for Nuclear Medicine
James J. Conway

Journal of Nuclear Medicine June 1, 2006, 47 (6) 14N-24N;
You have access
Connecting Our Past With the Future
Peter S. Conti

Journal of Nuclear Medicine June 1, 2006, 47 (6) 25N-26N;
You have access
National Oncologic PET Registry Begins Accepting Patient Data
Hugh Cannon

Journal of Nuclear Medicine June 1, 2006, 47 (6) 27N;
You have access
NEWSBRIEFS
Journal of Nuclear Medicine June 1, 2006, 47 (6) 28N-33N;
You have access
FROM THE LITERATURE
Journal of Nuclear Medicine June 1, 2006, 47 (6) 34N-42N;

Invited Perspectives

You have access
Targeted Radiotherapy: Is the “Holy Grail” in Sight?
Carmel Mothersill and Colin B. Seymour

Journal of Nuclear Medicine June 1, 2006, 47 (6) 899-900;
You have access
¹⁸F-FDG PET as a Candidate for “Qualified Biomarker”: Functional Assessment of Treatment Response in Oncology
Steven M. Larson and Lawrence H. Schwartz

Journal of Nuclear Medicine June 1, 2006, 47 (6) 901-903;

Clinical Investigations

You have access
¹⁸F-FDOPA PET Imaging of Brain Tumors: Comparison Study with ¹⁸F-FDG PET and Evaluation of Diagnostic Accuracy
Wei Chen, Daniel H.S. Silverman, Sibylle Delaloye, Johannes Czernin, Nirav Kamdar, Whitney Pope, Nagichettiar Satyamurthy, Christiaan Schiepers and Timothy Cloughesy

Journal of Nuclear Medicine June 1, 2006, 47 (6) 904-911;
You have access
Novel Human IgG2b/Murine Chimeric Antitenascin Monoclonal Antibody Construct Radiolabeled with ¹³¹I and Administered into the Surgically Created Resection Cavity of Patients with Malignant Glioma: Phase I Trial Results
David A. Reardon, Jennifer A. Quinn, Gamal Akabani, R. Edward Coleman, Allan H. Friedman, Henry S. Friedman, James E. Herndon, Roger E. McLendon, Charles N. Pegram, James M. Provenzale, Jeannette M. Dowell, Jeremy N. Rich, James J. Vredenburgh, Annick Desjardins, John H. Sampson, Sridharan Gururangan, Terence Z. Wong, Michael A. Badruddoja, Xiao-Guang Zhao, Darell D. Bigner and Michael R. Zalutsky

Journal of Nuclear Medicine June 1, 2006, 47 (6) 912-918;
You have access
Characterization of the SPECT 5-HT_2A Receptor Ligand ¹²³I-R91150 in Healthy Volunteers: Part 1—Pseudoequilibrium Interval and Quantification Methods
Ana M. Catafau, Monica Danus, Santiago Bullich, Jordi Llop, Javier Perich, Vincent J. Cunningham, Pedro Plaza, Maria M. Penengo, Jos L.H. Eersels, Lisa Squassante, Domenec Ros and Manel Barbanoj

Journal of Nuclear Medicine June 1, 2006, 47 (6) 919-928;
You have access
Characterization of the SPECT 5-HT_2A Receptor Ligand ¹²³I-R91150 in Healthy Volunteers: Part 2—Ketanserin Displacement
Ana M. Catafau, Monica Danus, Santiago Bullich, Gianluca Nucci, Jordi Llop, Sergi Abanades, Vincent J. Cunningham, Jos L.H. Eersels, Javier Pavia and Magi Farre

Journal of Nuclear Medicine June 1, 2006, 47 (6) 929-937;
You have access
Value of ¹¹C-Choline PET and Contrast-Enhanced CT for Staging of Bladder Cancer: Correlation with Histopathologic Findings
Maria Picchio, Uwe Treiber, Ambros J. Beer, Stefan Metz, Patrick Bössner, Heiner van Randenborgh, Roger Paul, Gregor Weirich, Michael Souvatzoglou, Rudolf Hartung, Markus Schwaiger and Morand Piert

Journal of Nuclear Medicine June 1, 2006, 47 (6) 938-944;
You have access
Comparison of Image-Derived and Arterial Input Functions for Estimating the Rate of Glucose Metabolism in Therapy-Monitoring ¹⁸F-FDG PET Studies
Lioe-Fee de Geus-Oei, Eric P. Visser, Paul F.M. Krabbe, Bas A. van Hoorn, Emile B. Koenders, Antoon T. Willemsen, Jan Pruim, Frans H.M. Corstens and Wim J.G. Oyen

Journal of Nuclear Medicine June 1, 2006, 47 (6) 945-949;
You have access
Effects of Pegfilgrastim on Normal Biodistribution of ¹⁸F-FDG: Preclinical and Clinical Studies
Heather A. Jacene, Takayoshi Ishimori, James M. Engles, Sophie Leboulleux, Vered Stearns and Richard L. Wahl

Journal of Nuclear Medicine June 1, 2006, 47 (6) 950-956;

Continuing Education

You have access
Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma
Tarik Z. Belhocine, Andrew M. Scott, Einat Even-Sapir, Jean-Luc Urbain and Richard Essner

Journal of Nuclear Medicine June 1, 2006, 47 (6) 957-967;

Erratum

You have access
Erratum
Journal of Nuclear Medicine June 1, 2006, 47 (6) 42N;
You have access
Erratum
Journal of Nuclear Medicine June 1, 2006, 47 (6) 903;

Basic Science Investigations

You have access
SPECT Imaging in the Diagnosis of Pulmonary Embolism: Automated Detection of Match and Mismatch Defects by Means of Image-Processing Techniques
Patrick Reinartz, Hans-Juergen Kaiser, Joachim E. Wildberger, Cirus Gordji, Bernd Nowak and Ulrich Buell

Journal of Nuclear Medicine June 1, 2006, 47 (6) 968-973;
You have access
Noninvasive Measurement of Cardiovascular Function in Mice with High-Temporal-Resolution Small-Animal PET
Michael C. Kreissl, Hsiao-Ming Wu, David B. Stout, Waldemar Ladno, Thomas H. Schindler, Xiaoli Zhang, John O. Prior, Mayumi L. Prins, Arion F. Chatziioannou, Sung-Cheng Huang and Heinrich R. Schelbert

Journal of Nuclear Medicine June 1, 2006, 47 (6) 974-980;
You have access
Characterization and Development of a Peptide (p160) with Affinity for Neuroblastoma Cells
Vasileios Askoxylakis, Walter Mier, Sabine Zitzmann, Volker Ehemann, Jianbing Zhang, Susanne Krämer, Carmen Beck, Manfred Schwab, Michael Eisenhut and Uwe Haberkorn

Journal of Nuclear Medicine June 1, 2006, 47 (6) 981-988;
You have access
Intertumoral Differences in Hypoxia Selectivity of the PET Imaging Agent ⁶⁴Cu(II)-Diacetyl-Bis(N⁴-Methylthiosemicarbazone)
Hong Yuan, Thies Schroeder, James E. Bowsher, Laurence W. Hedlund, Terence Wong and Mark W. Dewhirst

Journal of Nuclear Medicine June 1, 2006, 47 (6) 989-998;
You have access
Impact of Animal Handling on the Results of ¹⁸F-FDG PET Studies in Mice
Barbara J. Fueger, Johannes Czernin, Isabel Hildebrandt, Chris Tran, Benjamin S. Halpern, David Stout, Michael E. Phelps and Wolfgang A. Weber

Journal of Nuclear Medicine June 1, 2006, 47 (6) 999-1006;
You have access
Radiation-Induced Biologic Bystander Effect Elicited In Vitro by Targeted Radiopharmaceuticals Labeled with α-, β-, and Auger Electron–Emitting Radionuclides
Marie Boyd, Susan C. Ross, Jennifer Dorrens, Natasha E. Fullerton, Ker Wei Tan, Michael R. Zalutsky and Robert J. Mairs

Journal of Nuclear Medicine June 1, 2006, 47 (6) 1007-1015;
You have access
¹⁸F-FDG Assessment of Glucose Disposal and Production Rates During Fasting and Insulin Stimulation: A Validation Study
Patricia Iozzo, Amalia Gastaldelli, Mikko J. Järvisalo, Jan Kiss, Ronald Borra, Emma Buzzigoli, Antti Viljanen, G. Naum, Tapio Viljanen, Vesa Oikonen, Juhani Knuuti, Timo Savunen, Piero A. Salvadori, Ele Ferrannini and Pirjo Nuutila

Journal of Nuclear Medicine June 1, 2006, 47 (6) 1016-1022;
You have access
Preclinical Pharmacokinetic, Biodistribution, Toxicology, and Dosimetry Studies of ¹¹¹In-DTPA-Human Epidermal Growth Factor: An Auger Electron–Emitting Radiotherapeutic Agent for Epidermal Growth Factor Receptor–Positive Breast Cancer
Raymond M. Reilly, Paul Chen, Judy Wang, Deborah Scollard, Ross Cameron and Katherine A. Vallis

Journal of Nuclear Medicine June 1, 2006, 47 (6) 1023-1031;
You have access
First Evaluation of a ^99mTc-Tricarbonyl Complex, ^99mTc(CO)₃(LAN), as a New Renal Radiopharmaceutical in Humans
Malgorzata Lipowska, Haiyang He, Eugene Malveaux, Xiaolong Xu, Luigi G. Marzilli and Andrew Taylor

Journal of Nuclear Medicine June 1, 2006, 47 (6) 1032-1040;
You have access
Synthesis and In Vivo Evaluation of 2 High-Affinity ⁷⁶Br-Labeled σ₂-Receptor Ligands
Douglas J. Rowland, Zhude Tu, Jinbin Xu, Datta Ponde, Robert H. Mach and Michael J. Welch

Journal of Nuclear Medicine June 1, 2006, 47 (6) 1041-1048;
You have access
Log Normal Distribution of Cellular Uptake of Radioactivity: Implications for Biologic Responses to Radiopharmaceuticals
Prasad V.S.V. Neti and Roger W. Howell

Journal of Nuclear Medicine June 1, 2006, 47 (6) 1049-1058;

Special Contributions

You have access
Consensus Recommendations for the Use of ¹⁸F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials
Lalitha K. Shankar, John M. Hoffman, Steve Bacharach, Michael M. Graham, Joel Karp, Adriaan A. Lammertsma, Steven Larson, David A. Mankoff, Barry A. Siegel, Annick Van den Abbeele, Jeffrey Yap and Daniel Sullivan

Journal of Nuclear Medicine June 1, 2006, 47 (6) 1059-1066;

Main menu

User menu

Search

About the Cover

This Month in JNM

SNM Newsline

Invited Perspectives

Clinical Investigations

Continuing Education

Erratum

Basic Science Investigations

Special Contributions

In this issue

Jump to